265 related articles for article (PubMed ID: 30778704)
1. Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166.
von Lersner A; Droesen L; Zijlstra A
Clin Exp Metastasis; 2019 Apr; 36(2):87-95. PubMed ID: 30778704
[TBL] [Abstract][Full Text] [Related]
2. Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?
Swart GW; Lunter PC; Kilsdonk JW; Kempen LC
Cancer Metastasis Rev; 2005 Jun; 24(2):223-36. PubMed ID: 15986133
[TBL] [Abstract][Full Text] [Related]
3. Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration.
Swart GW
Eur J Cell Biol; 2002 Jun; 81(6):313-21. PubMed ID: 12113472
[TBL] [Abstract][Full Text] [Related]
4. ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression.
Ferragut F; Vachetta VS; Troncoso MF; Rabinovich GA; Elola MT
Cytokine Growth Factor Rev; 2021 Oct; 61():27-37. PubMed ID: 34272152
[TBL] [Abstract][Full Text] [Related]
5. ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9.
Gilsanz A; Sánchez-Martín L; Gutiérrez-López MD; Ovalle S; Machado-Pineda Y; Reyes R; Swart GW; Figdor CG; Lafuente EM; Cabañas C
Cell Mol Life Sci; 2013 Feb; 70(3):475-93. PubMed ID: 23052204
[TBL] [Abstract][Full Text] [Related]
6. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis.
Hebron KE; Li EY; Arnold Egloff SA; von Lersner AK; Taylor C; Houkes J; Flaherty DK; Eskaros A; Stricker TP; Zijlstra A
Sci Rep; 2018 Feb; 8(1):3208. PubMed ID: 29453336
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction.
van Kempen LC; Nelissen JM; Degen WG; Torensma R; Weidle UH; Bloemers HP; Figdor CG; Swart GW
J Biol Chem; 2001 Jul; 276(28):25783-90. PubMed ID: 11306570
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule.
van Kilsdonk JW; Wilting RH; Bergers M; van Muijen GN; Schalkwijk J; van Kempen LC; Swart GW
Cancer Res; 2008 May; 68(10):3671-9. PubMed ID: 18483249
[TBL] [Abstract][Full Text] [Related]
10. Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration.
Masedunskas A; King JA; Tan F; Cochran R; Stevens T; Sviridov D; Ofori-Acquah SF
FEBS Lett; 2006 May; 580(11):2637-45. PubMed ID: 16650408
[TBL] [Abstract][Full Text] [Related]
11. Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma.
van Kilsdonk JW; Takahashi N; Weidle U; Burtscher H; Jarry J; Daha MR; Swart GW; van Kempen LC
J Invest Dermatol; 2012 May; 132(5):1462-70. PubMed ID: 22318386
[TBL] [Abstract][Full Text] [Related]
12. Activated leukocyte cell-adhesion molecule (ALCAM) promotes malignant phenotypes of malignant mesothelioma.
Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Yokoi K; Osada H; Sekido Y
J Thorac Oncol; 2012 May; 7(5):890-9. PubMed ID: 22722789
[TBL] [Abstract][Full Text] [Related]
13. Activated leukocyte cell adhesion molecule regulates the interaction between pancreatic cancer cells and stellate cells.
Zhang WW; Zhan SH; Geng CX; Sun X; Erkan M; Kleeff J; Xie XJ
Mol Med Rep; 2016 Oct; 14(4):3627-33. PubMed ID: 27573419
[TBL] [Abstract][Full Text] [Related]
14. The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker.
Darvishi B; Boroumandieh S; Majidzadeh-A K; Salehi M; Jafari F; Farahmand L
Exp Mol Pathol; 2020 Aug; 115():104443. PubMed ID: 32380056
[TBL] [Abstract][Full Text] [Related]
15. Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function.
Ikeda K; Quertermous T
J Biol Chem; 2004 Dec; 279(53):55315-23. PubMed ID: 15496415
[TBL] [Abstract][Full Text] [Related]
16. ALCAM/CD166: cancer-related issues.
Weidle UH; Eggle D; Klostermann S; Swart GW
Cancer Genomics Proteomics; 2010; 7(5):231-43. PubMed ID: 20952758
[TBL] [Abstract][Full Text] [Related]
17. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
Jezierska A; Matysiak W; Motyl T
Med Sci Monit; 2006 Aug; 12(8):BR263-73. PubMed ID: 16865058
[TBL] [Abstract][Full Text] [Related]
18. ALCAM regulates motility, invasiveness, and adherens junction formation in uveal melanoma cells.
Jannie KM; Stipp CS; Weiner JA
PLoS One; 2012; 7(6):e39330. PubMed ID: 22745734
[TBL] [Abstract][Full Text] [Related]
19. Activated leukocyte cell adhesion molecule expression is up-regulated in the development of endometrioid carcinoma.
Liang S; Huang C; Jia S; Wang B
Int J Gynecol Cancer; 2011 Apr; 21(3):523-8. PubMed ID: 21430457
[TBL] [Abstract][Full Text] [Related]
20. Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth.
Ferragut F; Cagnoni AJ; Colombo LL; Sánchez Terrero C; Wolfenstein-Todel C; Troncoso MF; Vanzulli SI; Rabinovich GA; Mariño KV; Elola MT
Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1338-1352. PubMed ID: 30905597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]